ENDRA Life Sciences Inc. - NDRA

Sector: Healthcare · Industry: Electromedical & Electrotherapeutic Apparatus
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$1.016M
QoQ value delta ($000)
+$202K (+24.82%)
Implied price effect (QoQ)
+10.35%
Shares
Total shares
180,929
QoQ shares delta
+20,972 (+13.11%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (NDRA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 11 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Altium Capital Management LLC 324 54,528 0.47%
CITIZENS FINANCIAL GROUP INC/RI 169 28,400 0.0%
CITADEL ADVISORS LLC 159 29,924 0.0%
RENAISSANCE TECHNOLOGIES LLC 111 18,764 0.0%
GEODE CAPITAL MANAGEMENT, LLC 88 14,910 0.0%
VANGUARD FIDUCIARY TRUST CO 60 10,121 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 43 7,339 0.0%
UBS Group AG 35 5,942 0.0%
MORGAN STANLEY 21 3,546 0.0%
CITIGROUP INC 6 1,078 0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0 19 0.0%
Tower Research Capital LLC (TRC) 0 58 0.0%
Gleason Group, Inc. 0 6,300 0.0%